ArticleMicrobiologyOpen2025
Azotobacter vinelandii as a Nitrogen-Negative Chassis for Bio-Oil and Bio-Wax Production of Heterologous and Native Lipids.
Article in MicrobiologyOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The biosynthetic production of energy-dense petrochemical substitutes is an important goal to address sustainability. The diazotrophic soil microbe Azotobacter vinelandii is a model microbe for the study of biological nitrogen fixation. In addition to capturing atmospheric nitrogen and converting it into usable nitrogen compounds, it is also regarded for the ability to accumulate the bioplastic poly-β-hydroxybutyrate and the extracellular polysaccharide alginate. Here, we demonstrate the potential to broaden the chemical products repertoire of A. vinelandii by demonstrating the accumulation of several classes of biological lipids and waxes. These products include the expanded accumulation of wax esters and fatty alcohols through heterologous expression of foreign genes and pathways, and increased production of the native lipid alkylresorcinol, accomplished by deregulating specific internal pathways and removing competitive pathways for alternative products. As a result, we demonstrate a sevenfold increase in the accumulation of alkylresorcinol, manifesting as intracellular inclusions that are easily extracted with simple solvents and account for nearly 20% of the cellular biomass. By selecting a diazotrophic microbe as a chassis for lipid accumulation, we produced these lipids without any requirement for industrial nitrogen sources in the growth medium, resulting in a net positive nitrogen process as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.